Deals - Page 12 of 31 - Express Pharma

Halozyme to acquire Antares Pharma for $960 mn

Germany agrees deal with CureVac, GSK for mRNA vaccines until 2029

IAVI and Moderna partner to tackle global health priorities using mRNA for vaccines and antibodies

Pfizer to acquire ReViral and its Respiratory Syncytial Virus therapeutic candidates

Lupin completes acquisition of brands from Anglo-French Drugs and Industries

Lupin inks licensing pact with Alvion to market drugs in Southeast Asia

BSV acquires women’s health brand Tidilan

Zeon Lifesciences signs MoU with Delhi Pharma Sciences and Research University

Intas and Axantia sign licence and supply agreement for Ranibizumab biosimilar in Middle East

Fresenius agrees two acquisitions to bolster Kabi drugs unit